International Diversification: Why US-Only Portfolios Are a Bet, Not a Strategy
If your investment portfolio looks like a greatest hits album from the S&P 500, you are not diversified — you are concentrated. There is a meaningful difference, and confusing the two has cost a lot of people a lot of money across different decades and market cycles. The US market has delivered spectacular returns over the past fifteen years, which makes it psychologically very hard to argue against going all-in on it. But recency bias is not a strategy. It is a feeling dressed up as a strategy, and feelings make poor portfolio managers.
After looking at the evidence, a few things stood out to me.
Related: index fund investing guide
I teach Earth Science at Seoul National University, and I spend a significant portion of my working life helping students understand systems — how components interact, how feedback loops work, how a system that looks stable can tip suddenly. Portfolios are systems too. A US-only portfolio is a system with almost no redundancy built in, and redundancy is precisely what protects you when something unexpected happens. Which it always does.
The Home Bias Problem Is Real and It Is Widespread
Home bias — the tendency for investors to overweight their domestic market — is one of the most robustly documented phenomena in behavioral finance. Investors worldwide consistently hold far more of their own country’s equities than global market-cap weightings would suggest is rational (French & Poterba, 1991). For American investors, this bias is especially pronounced and especially seductive, because the US market is so large and so liquid that it can feel like enough.
But “enough” is doing a lot of work in that sentence. The US stock market represents roughly 60% of global market capitalization, which means that a US-only portfolio is ignoring 40% of the world’s publicly traded equity value. That 40% includes some of the world’s most productive companies, fastest-growing economies, and most significant infrastructure projects. Choosing not to participate in any of that is not a neutral act — it is a bet that the US will continue to outperform everything else, every decade, indefinitely.
That bet might pay off. It also might not. And a strategy built on a single bet is not really a strategy at all.
Understanding What “Diversification” Actually Means
Diversification is not about owning a lot of things. It is about owning things whose returns are not perfectly correlated with each other. If you own 500 US stocks, you own a lot of things, but they all share significant exposure to the same interest rate environment, the same Federal Reserve policy decisions, the same political climate, and the same currency. When the US market drops 30%, nearly all of those 500 stocks drop too.
International equities — particularly those in developed markets outside the US, and in emerging markets — have historically exhibited lower correlation with US equities over long time horizons. This means that when US stocks struggle, international stocks do not always struggle in the same way or to the same degree. Adding assets with lower correlations to a portfolio can reduce overall portfolio volatility without necessarily sacrificing expected returns, which is the core mathematical insight behind modern portfolio theory (Markowitz, 1952).
The correlation between US and international markets has increased since the 1990s as global financial integration has deepened. Critics of international diversification point to this as a reason to skip it. But even with higher correlations, the diversification benefit does not disappear entirely — it just becomes more modest. And modest improvements in risk-adjusted returns, compounded over decades, are not modest at all in absolute terms.
The Historical Record Does Not Support US Supremacy Forever
Here is something worth sitting with: the US stock market’s dominance over the past fifteen years is historically unusual, not historically typical. From 2000 to 2009 — a full decade — the S&P 500 produced a negative total return while international developed markets and emerging markets outperformed significantly. Investors who held only US equities during that period watched their portfolios go nowhere for ten years while those with international exposure saw genuine gains.
Go back further and the pattern of rotating leadership becomes even clearer. Japanese stocks massively outperformed US stocks through the 1980s. European markets led in various periods throughout the mid-twentieth century. Emerging markets went through an extraordinary run from roughly 2003 to 2007. Leadership rotates, and no single country or region stays on top forever. Dimson, Marsh, and Staunton (2002) analyzed equity returns across 16 countries from 1900 to 2000 and found that while the US delivered strong long-run returns, it was not the top-performing market over the full century — and that substantial variability existed across countries and time periods.
None of this means the US market is about to underperform. It might outperform for another decade. But betting everything on that outcome, without acknowledging that you are making a bet, is the kind of thinking that gets people into trouble at exactly the wrong time.
Valuation Matters, and Right Now It Matters a Lot
One of the most reliable long-run predictors of equity market returns is starting valuation. The cyclically adjusted price-to-earnings ratio, often called the CAPE or Shiller P/E, compares current prices to average earnings over the past ten years, smoothing out cyclical fluctuations. Higher CAPE ratios at the start of an investment period have consistently been associated with lower subsequent returns over the following ten to fifteen years.
As of recent years, US equity valuations by this measure have been elevated — significantly above their long-run historical average and significantly above valuations in most international markets. European equities, emerging market equities, and many smaller developed markets have been trading at substantially lower CAPE ratios. This does not guarantee that international markets will outperform, but it does mean the expected return differential currently favors international diversification more than it has at many points in the recent past.
Valuation-based return forecasting is not precise. Markets can stay expensive for a long time before reverting. But ignoring valuation entirely when constructing a portfolio is like ignoring the weather forecast because forecasts are sometimes wrong. Imperfect information is still information.
Currency Exposure: Risk or Feature?
One common objection to international investing is currency risk. When you own foreign equities, your returns in your home currency depend not just on the stock’s performance but on what happens to exchange rates. If you hold European stocks and the euro weakens against the dollar, your dollar-denominated returns will be lower even if the stocks themselves performed well.
This is a real consideration, not a dismissible one. But framing currency exposure purely as risk misses half the picture. Currency movements can also work in your favor — a strengthening euro would boost your dollar returns from European holdings. More importantly, over long time horizons, currency effects tend to be smaller than the effects of underlying equity returns, and they introduce a genuine source of diversification. The dollar itself is not a stable, risk-free asset — it fluctuates against other currencies based on trade balances, monetary policy, and geopolitical factors. Holding assets denominated in other currencies is a hedge against dollar weakness, not just a source of volatility.
Investors particularly concerned about currency volatility can access currency-hedged international ETFs, which strip out the currency exposure and deliver the underlying equity returns in their home currency. This is a tool worth knowing about, even if the unhedged version is often preferable over long horizons.
Emerging Markets: Higher Risk, Real Reward Potential
Emerging markets deserve their own discussion because they sit in a different risk category than developed international markets. Countries like India, Brazil, South Korea, Taiwan, and Vietnam have higher political risk, less regulatory transparency, and less liquid markets than the US or Western Europe. These are genuine risks that require genuine consideration.
But these countries also have younger populations, rapidly expanding middle classes, and significant untapped productivity gains ahead of them. The demographic and economic fundamentals in many emerging markets look considerably more favorable over the next thirty years than the demographics in aging developed economies. Harvey (1995) found that emerging market equities exhibited higher expected returns than developed markets, partially as compensation for their higher risk and lower integration with global markets — a premium that has appeared and disappeared across different periods but that represents a theoretically sound reason to expect compensation for bearing that risk.
A reasonable approach is not to overweight emerging markets dramatically but to hold them at something close to their global market-cap weight — roughly 10-15% of a total equity allocation — as a long-term position that captures their growth potential without making an outsized bet on any single country or region.
How Much International Is the Right Amount?
There is no single right answer to this question, and anyone who gives you a precise number with great confidence is overstating what the evidence can tell us. That said, there are sensible frameworks.
Global market-cap weighting — which would imply roughly 40% international exposure in a total equity portfolio — is a theoretically defensible starting point because it reflects the collective judgment of all market participants about where value lies. Many institutional investors and target-date fund providers use allocations in the range of 30-40% international as a baseline.
For individual investors, there are legitimate reasons to hold somewhat less than market-cap weight in international equities. Home-country bias is not entirely irrational — if your expenses are in dollars, there is a currency-matching argument for holding more dollar-denominated assets. Transaction costs and tax treatment of foreign dividends can slightly disadvantage international holdings in some account structures. These are real factors.
But there is a substantial distance between “somewhat less than 40%” and “zero.” An allocation of somewhere between 20% and 35% of total equity exposure in international assets — split between developed international and emerging markets — captures most of the diversification benefit while accommodating reasonable home-country preferences. The exact split matters less than the decision to have meaningful international exposure at all.
Practical Implementation Without Overthinking It
If you have ADHD like I do, or if you just have a busy life as most knowledge workers do, the implementation piece needs to be simple enough that you will actually do it and not constantly tinker with it afterward. Complexity is the enemy of follow-through.
A few low-cost index funds or ETFs can accomplish everything you need. A total international stock market index fund covers both developed and emerging markets in a single fund. Combined with a US total market fund, you can construct a globally diversified equity portfolio with two holdings. Add a bond fund if your risk tolerance or time horizon calls for it, and you have a complete portfolio that requires rebalancing once a year at most.
The expense ratios on broad international index funds have fallen dramatically over the past decade, with many options now available below 0.10% annually. The cost argument against international diversification has largely collapsed. The main remaining argument against it is the behavioral one — it felt bad to hold international stocks during the US bull market of 2010-2021, and that discomfort leads investors to abandon the strategy at exactly the wrong time. Understanding why you hold international assets in the first place is the immunization against that behavioral failure.
Does this match your experience?
The Confidence Trap
The biggest obstacle to international diversification is not information — it is overconfidence. When the US market has significantly outperformed for years, the narrative explaining that outperformance becomes very compelling. American corporate governance is superior. US companies are more innovative. The dollar is the world’s reserve currency. These explanations feel like structural advantages that will persist forever.
Some of those advantages are real. None of them are permanent. Every market cycle in history has produced compelling narratives explaining why this time the leader will stay the leader — Japanese manufacturing excellence in the 1980s, emerging market growth stories in the 2000s, US tech dominance today. The narratives are always partially true. They are never the whole story. Excessive faith in current narratives is precisely what Kahneman (2011) identified as a core feature of human overconfidence — the tendency to construct coherent explanations for patterns and then treat those explanations as more certain than the underlying evidence warrants.
Building a portfolio that depends on any single narrative being permanently correct is not investing. It is speculating with your long-term financial security. International diversification is not a complicated or exotic strategy. It is simply the acknowledgment that you do not know exactly which markets will lead over the next twenty years, and that holding a broader set of assets is a more honest response to that uncertainty than pretending the question has an obvious answer.
The US market may well continue to deliver strong returns. If it does, a globally diversified portfolio will still participate in that growth — just with some weight also in other markets that may or may not keep pace. That is not a sacrifice. That is what a real strategy looks like.
Related Reading
Last updated: 2026-03-31
Your Next Steps
- Today: Pick one idea from this article and try it before bed tonight.
- This week: Track your results for 5 days — even a simple notes app works.
- Next 30 days: Review what worked, drop what didn’t, and build your personal system.
Disclaimer: This article is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with any questions about a medical condition.
My take: the research points in a clear direction here.
What is the key takeaway about international diversification?
Evidence-based approaches consistently outperform conventional wisdom. Start with the data, not assumptions, and give any strategy at least 30 days before judging results.
How should beginners approach international diversification?
Pick one actionable insight from this guide and implement it today. Small, consistent actions compound faster than ambitious plans that never start.